Arizona Bioscience

Biotechnology Growth in Arizona

Arizona Bioindustry Association

M&A

M&A: Fundamental to Pharma Industry Growth

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Gene Therapy

Introduction: The Promise & Challenge of Gene Therapy

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Glocalization

Introduction: Glocalization

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

FDA

The FDA Changes the Drug Approval Process

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Biologics

Building a Biologics Business from the Ground Up

Hannes Teissl

Polpharma Biologics

FDA

Safety Concerns Raised about Valsartan from China

Nice Insight

Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Investment

Investing in Chinese Pharma Companies Proves Profitable

Guy Tiene

Nice Insight

Mergers & Acquisitions

Inside Mergers & Acquisitions

Kevin Bottomley

Results Healthcare

Investment

Taking Middle-Market CROs and CDMOs to the Next Level

Jeffrey Marlough

Castleford Capital

Immunotherapy

Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

Nigel Walker

Nice Insight

Used Equipment

With Expertise Comes Security

Matt Hicks

Federal Equipment Company

Acquisition

Takeda Acquires Shire for $62 Billion

Emilie Branch

Pharma's Almanac

Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

Guy Tiene

Nice Insight

Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

Sébastien Mathieu; Laurent Dray

Servier